ANALISIS EFEKTIVITAS BIAYA (Cost Effectiveness Analysis) PENGGUNAAN ANTIPSIKOTIK MONOTERAPI ATIPIKAL DENGAN KOMBINASI ATIPIKAL DAN TIPIKAL PADA PASIEN RAWAT INAP SKIZOFRENIA DI RUMAH SAKIT JIWA GRHASIA YOGYAKARTA

Authors

  • Novi Afitriyani Universitas Alma Ata
  • Eliza Dwinta Program Studi Sarjana Farmasi, Fakultas Ilmu-Ilmu Kesehatan Universitas Alma Ata
  • Imram Radne Rimba Putri Program Studi Administrasi Rumah Sakit, Fakultas Ilmu-Ilmu Kesehatan Universitas Alma Ata
  • Witri Susila Astuti Instalasi Farmasi, Rumah Sakit Daerah Panembahan Senopati Bantul, Daerah Istimewa Yogyakarta

DOI:

https://doi.org/10.36387/jiis.v8i3.1656

Keywords:

Cost Effectiveness Analysis (CEA), Pharmacoeconomics, Schizophrenia

Abstract

Schizophrenia is a serious mental disorder characterized by impaired thinking, hallucinations and social behavior. Yogyakarta Special Region (DIY) ranks 2nd with a prevalence of schizophrenia reaching 10.4 per 1,000 population. The high number of people suffering from mental disorders can lead to increasingly expensive costs. To reduce the problem of health financing, a cost-effectiveness analysis is needed by calculating the cost of antipsychotic drugs and calculating the Average Cost Effectiveness Ratio value. The aim of this study was to determine the cost-effectiveness of using atypical antipsychotic monotherapy with atypical and typical combinations in schizophrenia patients at RSJ Grhasia Yogyakarta. The research method was carried out descriptively and retrospectively using medical record data for the period January-December 2022, with a proportional sampling technique. Results: research shows that atypical monotherapy antipsychotics are more cost-effective with an Average Cost Effectiveness Ratio value of IDR 204.4/week of therapeutic treatment compared to atypical-typical combination antipsychotics with a greater value of IDR 343.2/week of therapeutic treatment. Conclusion: The antipsychotics used by inpatient schizophrenia patients at RSJ Grhasia Yogyakarta had the highest effectiveness, namely in the atypical monotherapy therapy group, amounting to (93.02%).

References

Andayani, T.M. (2013) Farmakoekonomi Prinsip dan Metodologi. Yogyakarta: Bursa Ilmu.

Aryani, F. et al. (2017) ‘Analisis Efektivitas Biaya Dan Terapi Antipsikotik Haloperidol-Klorpromazin Dan Risperidon-Klozapin Pada Pasien Skizofrenia’, PHARMACY, 14(01), pp. 98–107.

Bimantara, W., Lolo, Widya A. and Jayanto, I. (2021) ‘Cost Minimization Analysis Of Using Risperidone And Haloperidol In Schizophernic Patients In A Mental Hostipal Dr. V. L. Ratumbuysang’, Pharmacon, 10(November), pp. 1190–1198. Available at: https://ejournal.unsrat.ac.id/index.php/pharmacon/article/download/37418/34514%0A.

Bimantara, W., Lolo, Widya A and Jayanto, I. (2021) ‘Cost Minimization Analysis Of Using Risperidone And Haloperidol In Schizoprenic Patients In A Mental Hospital Dr. V. L. Ratumbuysang’, 10(November), pp. 1190–1198.

Depkes, R. (2019) ‘Riset Kesehatan Dasar 2018. Jakarta. Badan Penelitian dan Pengembangan Kesehatan Republik Indonesia’. Available at: https://www.dinkes.jogjaprov.go.id/berita/detail/riskesdas-2018gangguan-jiwa-berat--riskesdas-2018--gangguan-jiwa-berat-di-diy-melejit-urutan-2-nasional.

Fisher, G. and Roget, N. (2014) ‘Diagnostic and Statistical Manual of Mental Disorders’, Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery, pp. 4–8. doi:10.4135/9781412964500.n104.

Gearing, R.E. et al. (2023) ‘Public Stigma Toward Schizophrenia Within Latino Communities in the United States’, PubMed Central (PMC), 59(5), pp. 915–928. doi:10.1007/s10597-022-01075-w.

Georgiopoulos, A.M. (2008) ‘The DSM-IV-TR: A Multiaxial System for Psychiatric Diagnosis’, Massachusetts General Hospital Comprehensive Clinical Psychiatry, pp. 205–214. doi:10.1016/b978-0-323-04743-2.50019-6.

Indrawaty, S. et al. (2013) Pedoman Penerapan Kajian Farmakoekonomi. Edited by P. Sarnianto, Z. Fadia, and E. Gusnellyanti. Jakarta: Kementrian Kesehatan Republik Indonesia. Available at: http://farmalkes.kemkes.go.id/unduh/pedoman-penerapan-kajian-farmakoekonomi/.

Kurnia Utami, I., Barliana, M.I. and Halimah, E. (2022) ‘Cost Analysis of Antipsychotics Schizophrenia of Inpatients in Mental Hospital West Java Province’, Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 8(2), pp. 143–153. doi:10.22487/j24428744.2022.v8.i2.15959.

Maylani, R.Y. (2018) ‘Studi Pemberian Antipsikotik Terhadap Beberapa Jenis Skizofrenia Di RSJD Atma Husada Mahakam Samarinda’, Angewandte Chemie International Edition, 6(11), 951–952., 3(1), pp. 10–27. Available at: https://medium.com/@arifwicaksanaa/pengertian-use-case-a7e576e1b6bf.

Muhareni1, D. et al. (2021) ‘Analisis Efektivitas Biaya Terapi Olanzapin Dan Kombinasi Haloperidol Dengan Diazepam Secara Intramuskular Pada Pasien Rawat Inap Skizofrenia Fase Akut Di Rskd Duren Sawit’, Original Article MFF, 25(1), pp. 28–31. doi:10.20956/mff.v25i1.11561.

Mulyaningsih, Endriyani, L. and Arifah, S. (2016) Hubungan Antara Caregiver Burden Dengan Kualitas Hidup Keluarga Skizofrenia Di Poli Rumah Sakit Jiwa Grhasia Yogyakarta, Universitas Alma Ata.

Murtini, T., Anggriani, Y. and Purba, F.D. (2022) ‘Analisis efektivitas biaya aripriprazol dengan olanzapin pada pasien rawat inap skizofrenia di ruang tenang rskd duren sawit’, Majalah Farmasi dan Farmakologi, 26(3), pp. 114–118. doi:10.20956/mff.v26i3.19099.

Nedyastuti, Rahmawati, S. (2021) ‘Studi Kasus Pasien Skizofrenia Ny. D dengan Gangguan Halusinasi Pendengaran di Ruang Dewi Kunthi di Rumah Sakit Jiwa Prof. Dr. Soeroyo Magelang’, Seminar Nasional Penelitian dan Pengabdian Kepada Masyarakat, pp. 1041–1049. Available at: https://prosiding.uhb.ac.id/index.php/SNPPKM/article/view/923.

Rony, F.Q. and Pardilawati, C.Y. (2023) Analisis Cost Of Illness pada Pasien Skizofrenia di Poliklinik Psikiatri Rumah Sakit Jiwa Daerah Provinsi Lampung Cost Of Illness Analysis of Schizophrenia Patients at Psychiatri Policlinic Lampung Province Mental Hospital, Jurnal Kedokteran Unila. Universitas Alma Ata.

Surbakti, C.I., Sinaga, T.A. and Sianipar, A.Y. (2022) ‘Profil Penggunaan Obat Antipsikotik Pada Pasien Orang Dengan Gangguan Jiwa (Odgj) Di Upt. Puskesmas Helvetia Kota Medan’, Journal of Pharmaceutical And Sciences, 5(2), pp. 187–192. doi:10.36490/journal-jps.com.v5i2.115.

Tribunjogja.com. (2018) ‘Jumlah gangguan jiwa di Yogyakarta tertinggi di Indonesia’. Available at: https://jogja.tribunnews.com/2018/02/21/jumlah-penderita-gangguan-jiwa-di-diy-tertinggi-di-indonesia.

Yosep, I. (2016) Keperawatan Jiwa dan Advance Mental Health Nursing. Bandung: PT. Refika Aditama.

Zaera Feridina Azzahroh (2019) ‘Terapi Pasien Schizophrenia Pada Laki-Laki’. Available at: https://www.researchgate.net/publication/334021668_Terapi_Pasien_Skizofrenia_Pada_Laki-Laki.

Zahnia, S. and Wulan Sumekar, D. (2016) ‘Kajian Epidemiologis Skizofrenia’, Majority, 5(5), pp. 160–166. Available at: http://juke.kedokteran.unila.ac.id/index.php/majority/article/view/904/812.

Published

2024-01-31

How to Cite

ANALISIS EFEKTIVITAS BIAYA (Cost Effectiveness Analysis) PENGGUNAAN ANTIPSIKOTIK MONOTERAPI ATIPIKAL DENGAN KOMBINASI ATIPIKAL DAN TIPIKAL PADA PASIEN RAWAT INAP SKIZOFRENIA DI RUMAH SAKIT JIWA GRHASIA YOGYAKARTA. (2024). Jurnal Ilmiah Ibnu Sina, 8(3), 46-56. https://doi.org/10.36387/jiis.v8i3.1656

Similar Articles

11-20 of 82

You may also start an advanced similarity search for this article.